Navigation Links
MedShape Solutions, Inc. Announces Commercialization of SBIR Funded Technology: Receives Purchasing Preference in Federally Funded Hospitals and Health Care Facilities
Date:3/5/2010

ATLANTA, March 5 /PRNewswire/ -- MedShape Solutions announced today that it is pursuing Phase III SBIR awards and has received preferred vendor status at Veterans Health Administration Hospitals and other Federally funded hospitals for its MORPHIX ™ Shape Memory Suture Anchor.  The MORPHIX device was developed with financial assistance through NIH/NIAMS Grants # 1R43AR056154-01, 2R44AR056154-02, 5R44AR056154-03.  The MORPHIX Anchor is being highlighted and launched nationally at the American Academy of Orthopedic Surgeons meeting in New Orleans, March 10-13, 2010.

The Small Business Act Policy Directive provides that "Government owned, contractor operated facilities….give preference including sole source awards to the awardee that developed the technology."  Section 4 (c) (7)  The Directive also states that "the competition for SBIR Phase I and Phase II awards satisfies any competition requirement of the Armed Services Procurement Act, The Federal Property and Administrative Services Act and the Competition in Contracting Act."  Section 4 (c) (3)

"The development of the MORPHIX Suture Anchor with SBIR support was a textbook case of how a partnership in development should occur.  The grant funding received was critical to the development success and eventual commercialization of this innovative technology," stated Chris Fair, Chief Operations Officer of MedShape Solutions.

MedShape Solutions initial product is the MORPHIX Suture Anchor made from proprietary shape memory PEEK Altera.   "We anticipate releasing additional technologies in the months ahead that were  supported via SBIR Phase I & Phase II awards for their development.  These technologies will also receive the same preferred supplier status within their product category," stated Kurt Jacobus, PhD, President & CEO of MedShape Solutions.

MedShape Solutions is a privately held company focused on developing orthopedic devices from proprietary shape memory technology.  You may find more information at www.medshape.com.

If you are a government purchasing group and would like additional information, please contact Chris Fair, Chief Operating Officer of MedShape Solutions at (404) 249-9155 or send an email to gov@medshape.com .

SOURCE MedShape Solutions, Inc.

Back to top

RELATED LINKS
http://www.medshape.com

'/>"/>

SOURCE MedShape Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
2. RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™
3. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
4. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
5. Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
6. Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
7. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
8. Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister
9. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
10. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
11. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... and solutions to the healthcare market. The company's primary focus is on new ... and marketing strategies that are necessary to help companies efficiently bring their products ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
(Date:6/9/2016)... -- Perkotek an innovation leader in attendance control systems is proud to announce the introduction ... to make sure the right employees are actually signing in, and to even control ... ... ... ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):